MedTrace Logo

Assessment of Suspected Intracranial Malignancy Using 3'-Deoxy-3'18 F-flourothymidine PET

NCT00775320 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2019-11-25

No results posted yet for this study

Summary

The primary objective of this study is to detect and quantify tumor cells of high grade malignant gliomas and metastatic brain lesions both before and after initial surgical resection in a cohort of newly diagnosed patients.

Conditions

Interventions

PROCEDURE

FLT-PET scan

Imaging test

Sponsors & Collaborators

  • Midwest Medical Isotopes

    collaborator UNKNOWN

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Jennifer Holter, MD · Assistant Professor

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2010-08-31
Completion
2010-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00775320 on ClinicalTrials.gov